FoI Number
2024-583
Subject
Biologics
Date Received
03/01/2025
Request and Response

Could you please provide the numbers of patients treated by the rheumatology department (for any condition) in the last 3 months with the following drugs:

In accordance with FOISA s 17(1), NHS Shetland confirms that it does not hold the information requested. NHS Shetland does not have a Rheumatology Department.

 

•           Abatacept [Orencia]

•           Adalimumab [Humira]

•           Adalimumab Biosimilars

•           Apremilast [Otezla]

•           Baricitinib [Olumiant]

•           Bimekizumab [Bimzelx]

•           Certolizumab [Cimzia]

•           Etanercept [Enbrel]

•           Etanercept Biosimilars

•           Filgotinib [Jyseleca]

•           Golimumab [Simponi]

•           Guselkumab [Tremfya]

•           Infliximab [Remicade]

•           Infliximab Biosimilars

•           Ixekizumab [Taltz]

•           Risankizumab [Skyrizi]

•           Rituximab [MabThera]

•           Rituximab Biosimilars

•           Sarilumab [Kevzara]

•           Secukinumab [Cosentyx]

•           Tocilizumab [Ro Actemra]

•           Tocilizumab Biosimilars

•           Tofacitinib [Xeljanz]

•           Upadacitinib [Rinvoq]

•           Ustekinumab [Stelara]

•           Ustekinumab Biosimilar